These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 2810116)

  • 1. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    Ehlert FJ; Delen FM; Yun SH; Friedman DJ; Self DW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of amitriptyline, doxepin, imipramine and their N-methyl quaternary ammonium derivatives with subtypes of muscarinic receptors in brain and heart.
    Ehlert FJ; Delen FM; Yun SH; Liem HA
    J Pharmacol Exp Ther; 1990 Apr; 253(1):13-9. PubMed ID: 2329499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
    Candell LM; Yun SH; Tran LL; Ehlert FJ
    Mol Pharmacol; 1990 Nov; 38(5):689-97. PubMed ID: 2172776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.
    Korc M; Ackerman MS; Roeske WR
    J Pharmacol Exp Ther; 1987 Jan; 240(1):118-22. PubMed ID: 2433426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ
    J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptor binding and muscarinic receptor-mediated inhibition of adenylate cyclase in rat brain myelin.
    Larocca JN; Ledeen RW; Dvorkin B; Makman MH
    J Neurosci; 1987 Dec; 7(12):3869-76. PubMed ID: 3694257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors.
    Miller JH; Gibson VA; McKinney M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):601-7. PubMed ID: 1941609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S; Buckley NJ; Roberts FF
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
    Gillard M; Waelbroeck M; Christophe J
    J Recept Res; 1986; 6(1):47-61. PubMed ID: 3754901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
    Tränkle C; Andresen I; Lambrecht G; Mohr K
    Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
    Dickinson KE; Matsumoto H; Anderson W; Pruitt RE; Uemura N; Hirschowitz BI
    J Pharmacol Exp Ther; 1988 Sep; 246(3):879-86. PubMed ID: 2901489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the interaction of gallamine with muscarinic receptor subtypes.
    Michel AD; Delmendo RE; Lopez M; Whiting RL
    Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin, dextran and trypan blue allosterically modulate M2 muscarinic receptor binding properties and interfere with receptor-mediated inhibition of adenylate cyclase.
    Gerstin EH; Luong T; Ehlert FJ
    J Pharmacol Exp Ther; 1992 Dec; 263(3):910-7. PubMed ID: 1281880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.